# Generative AI company Abridge scores $300M series E backed by a16z and Khosla Ventures - Fierce Healthcare

## Metadata
| Field | Value |
|-------|-------|
| Source | Fierce Healthcare |
| URL | https://news.google.com/rss/articles/CBMixgFBVV95cUxNcWlReUZxd0lSVnlXckFHb1o4d0hQMGdUTER1RENPU2R3ZlJSc3ZnQmFBMmVkc1NhRGZyTWE5MGdIWEFXbGVneXI0dlJjYkdXeUJaNmlJSGVzbko0TU53UUhYTWJjZGNsRWZFTkh4TklYZXhDa2o1RkZGNC1DM2xQaUwzXzRBdS1sMUo3dWxNV2FYb1BWR0N1b0lPVVRISWR3OW1idWtrNlA1b21MUmhXVzJQM3Z3aXJrQUtYOUhHc1FXV2VNVWc?oc=5&hl=en-US&gl=US&ceid=US:en |
| Scraped | 2025-12-30 07:00 |
| Category | AI |
| Relevance | 9/10 |
| Signal | bull |

## Investment Summary
Abridge, a generative AI healthcare documentation platform, secured a significant $300M Series E round from top-tier healthcare and tech VCs, signaling strong investor confidence in clinical AI solutions.

## Key Entities
Abridge, a16z, Khosla Ventures

## Dollar Amounts
$300M

---

## Article Content

*Full content could not be extracted. Visit URL for details.*

---

#healthcare-news #ai #auto-scraped
